GFAP and neoplasm: As gut inflammation is known to accelerate tumor growth in the AOM/DSS model, and enteric glia can secrete and respond to inflammatory mediators (17, 35–37), we investigated whether the GFAP+ enteric glia could be promoting tumor development by exacerbating intestinal inflammation.